2月6日（二）
Registration
Organizer's Welcome Remarks
Landing Commercial Contracts with Large Healthcare Enterprises
Christine Brocato, System Vice President, Strategic Innovation, CommonSpirit Health
Landing contracts with large healthcare organizations is more challenging than ever in this tight economic environment. And yet some companies are managing to pull it off. This panel will consist of perspectives from experts on both sides of the negotiation table to discuss what healthcare organizations are looking for when considering an enterprise contract, and practical advice and tips from companies who are successfully attaining enterprise contracts.
Connie Chen, MD, COO, Lyra Health
Michael B. Roaldi, Senior Vice President, Growth at UnitedHealthcare Community & State, UnitedHealthcare Community & State
Kristina Saffran, Co-Founder & CEO, Equip
Sara Vaezy, Executive Vice President, Chief Strategy and Digital Officer, Providence
Cooley Capital Call at DHIS-West connects investors to high-potential companies seeking funding. Pre-selected innovative companies will pitch to a panel of judges. The winner will be featured in a fireside chat with Josh Seidenfeld, Partner and Chair, Digital Health at Cooley on February 7th.
Transition to Breakout Sessions
Sponsored Presentation (Opportunity Available)
Welcome Networking Reception
Close of Day
2月7日（三）
Registration and Morning Coffee
The Reinvention of Clinical Trials by Digital Health
Vinay M Shah, Partner and Founding Team Member, Transformation Capital
This panel offers a comprehensive look at how digital health technologies are reshaping clinical trial processes. The discussion will focus on how tech-enabled approaches enhance trial efficiency and patient engagement. We will also examine the challenges and opportunities presented by this digital shift, including its impact on data collection methods and the evolving regulatory landscape
Stephen Buck, Co-Founder and Chief Product Officer, Trial Library
Edward Cox, Head & General Manager, Digital Health & Medicines (DHM), Pfizer, Inc.
Jonathan Hirsch, Chief Strategy and Growth Officer, Paradigm
Ramita Tandon, Chief Clinical Trials Officer, Walgreens
Networking Coffee Break
Dyna - Generative AI for Fast, Trustworthy Clinical Answers
Julia Colpitts, Vice President, Product Management, EBSCO Clinical Decisions
Dyna is a retrieval augmented generation (RAG)-based capability which offers instantaneous answers to clinical questions from within our “walled garden” of evidence-based, expert-curated information and tools. Our walled garden is the DynaMedex® and Dynamic Health clinical content collections designed for physicians, advanced providers, pharmacists, nurses, and health professionals.
Transition to General Session
Exploring Current Financing Trends and the Evolving Landscape of Digital Health Investments
Josh Seidenfeld, Partner & Chair, Digital Health, Cooley
Investors will divulge what shapes their investment criteria and how you can best position your company in the current funding climate. Discussion topics will include investment trends, peak areas of interest, and predictions for 2024. Learn what it takes to secure a lead investor and how to stand out while competing for capital. This session will be a candid conversation with decision-makers who are actively investing in the space!
Justin W Butler, Partner, Eclipse
Christiana DelloRusso, PhD, Partner, LRVHealth
Matt Emery, General Partner, JMI Equity
Networking Lunch
KEYNOTE FIRESIDE CHAT: Interview with the Recipient of the 2024 West Coast Digital Healthcare Innovator Award
Tom X. Lee, MD, CEO, Galileo
Building a successful digital health company is hard. Creating two companies that have gone public and trying to redesign how care is provided - even harder! Hear from Tom Lee, our Healthcare Innovator Award winner, about his journey, lessons learned, and why he decided to do it again with Galileo.
Michelle Snyder, Partner, McKesson Ventures
Town Hall-Which Topics Are Front-of-Mind?
Missy Krasner, Venture Chair, Redesign Health
Fatima Paruk, MD, Senior Vice President & Chief Health Officer, Health & Life Sciences, Salesforce, Inc.
Lee Shapiro, Managing Partner, 7wire Ventures
This session gives you the chance to address the biggest issues facing our industry. Your moderators will prompt you on topics that could include:
Stroke-of-the-Pen Risk: How Regulatory Landscape in Election Year Will Affect Digital Health
Anna Haghgooie, Managing Director, Valtruis; Operating Partner, Welsh, Carson, Anderson & Stowe (WCAS)
Hear from a group of experienced leaders in the policy and regulatory circles about how focus and direction might shift, or stay the course, depending on the outcome of the election in November.
Julie Barnes, Founder & Principal, Maverick Health Policy
Mandira Singh, Fractional Executive and Advisor
Kyle Zebley, Senior Vice President, Public Policy, American Telemedicine Association
Networking Refreshment Break
Breaking through Value-Based Care: Will Non-Medical Benefits Finally Do It?
Rajaie Batniji, MD, PhD, Co-Founder & CEO, Waymark
Value-based care (VBC) is increasingly being discussed as a sustainable source of funding for evidence-based interventions that address social needs. What is required for these programs to successfully deliver whole-person care? Forward-thinking payers and providers are experimenting with new approaches that place non-clinical staff at the center of care. In this session, you’ll learn: The challenges with the traditional “screen and refer” approach to addressing patients’ social needs. Why a 'Social ACO' model led by non-clinical staff can enable PCPs to move care outside the clinic. The role of the health plan as an enabler of population health coordination
Scott Anders, MD, CMO, Value-Based Care, Providence Clinical Network
Sanjiv Baxi, MD, PhD, MPH, FIDSA, Partner, McKinsey & Company
Dipa D Patolia, Senior Director of Population Health & Clinical Operations, Health Net
Irem Rami, Principal, Healthcare, Norwest Venture Partners
Generative AI in Healthcare: Hype or Hope
Julie Yoo, General Partner, a16z
The AI revolution is here, and it’s poised to make a greater impact on healthcare than any other industry. But, is Dr. ChatGPT really on the horizon? During this interactive panel, industry leaders will discuss the tangible progress that’s been made, which tools are worth the hype (and which are not), and chart the realities-and sensationalism-around how generative AI will reshape the future of health systems, care delivery, personalized treatments, and more.
Ashok Chennuru, Global Chief Data & Insights Officer, Elevance Health
Aabed Meer, MD, Partner, Questa Capital
Tarun Mehra, Vice President, Healthcare Strategy, M&A and Partnerships, Microsoft (Nuance)
Munjal Shah, Co-Founder and CEO, Hippocratic AI
Networking Reception
Close of Summit
* 欲了解更多详情，请联络环球资讯有限公司。
